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Abstract Interleukin (IL) 7 is an important cytokine regulating both T and B cell development a d inducing the formation oflymphokine-activated 
killer cells and eytolytie T lymphocytes. This study reports the role of JAK family kinases in the IL-7 signalling pathway in a T cell clone. The results 
have shown that out of 4 members of JAK family tyrosine kinases (JAK1, JAK2, JAK3 and Tyk2), only JAK3 was tyrosine-phosphorylated nd 
activated in cells of a T cell clone by stimulation with IL-7. Furthermore, STATI0~ (STAT, the signal transducers and activators of transcription) 
and p44 of MAPK (mitogen-activated protein kinases) were tyrosine phosphorylated by IL-7 stimulation, indicating that the two signal pathways 
might be involved in IL-7 signal transduetion. 
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1. Introduction 
Interleukin 7 (IL-7) was originally discovered as a pre-B cell 
growth factor in long-term bone marrow culture system [1]. But 
subsequent s udies howed that this factor elicited a variety of 
biological activities and affected T cells as well as pre-B cells 
[2,3]. More intriguingly, IL-7 is capable of induce the formation 
of lymphokine-activated killer (LAK) cells and cytolytic T lym- 
phocytes (CTL) from both murine and human T cells [4,5]. 
Thus, IL-7 is an important factor for the regulation of both B 
and T cell development and may have therapeutic applications 
in cancer immunotherapy and treatment of immunodeficiency 
diseases. However, the mechanism by which IL-7 receptor 
transmit signals after IL-7 binding remains elusive, although 
the receptor for IL-7 was cloned several years ago [6] and 
protein tyrosine kinases might be involved in it [7]. 
A number of growth factor receptors, such as PDGF-R, 
FGF-R,  NGF-R and IGF-R, have tyrosine kinase domains in 
their cytoplasmic regions and are capable of mediating biolog- 
ical response by activating their intrinsic kinase activity, while 
most of the cytokine receptors lack such kind ofkinase activity 
and additional cytoplasmic tyrosine kinases are required to 
transmit signals from the receptors to downstream olecules 
[8]. In the last two years, a large number of studies identified 
the important role of JAK family tyrosine kinases (JAKs) in 
signal transduction of cytokines. Namely, JAKs are physically 
associated with the membrane-proximal region of specific re- 
ceptors for cytokines and are phosphorylated and activated by 
the binding of ligand with corresponding receptors, resulting 
in the activation of downstream transcription factors called the 
signal transducers and activators of transcription (STATs) [9]. 
Recently, the fourth member of this family, JAK3, was cloned 
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and found to be related with the signal pathway of interleukin 
2 (IL-2) and interleukin 4 (IL-4) [10-12]. Since the third mole- 
cule of IL-2R, 7 chain, also composes a part of receptors for 
IL-4 and IL-7 [13] and is physically associated with JAK1 and 
JAK2 tyrosine kinases [14], it is likely that JAK3 also plays a 
role in IL-7 signal pathway. Accordingly, in the present s udy, 
we examined whether the stimulation with IL-7 can induce the 
tyrosine phosphorylation a d activation of JAK3 in a T cell 
clone and the result clearly showed tyrosine phosphorylation 
of JAK3 in dose- and time-dependent manners, when the cells 
were stimulated with IL-7. Moreover, in association with acti- 
vation of JAK3, we found that STAT1 and mitogen-activated 
protein kinases (MAP Kinases) are also activated in the cell line 
by IL-7 stimulation. 
2. Materials and methods 
2.1. Cell culture 
A murine T helper cell clone (YT-5) was kindly provided by Dr. 
Nariuehi (Inst. Med. Sci. Univ. of Tokyo). This cell line was maintained 
in RPMI-1640 media in the presence of 10% of fetal bovine serum 
(FBS) and 10% of culture supernatant of Con A-stimulated rat spleen 
cells, and receiving repeated stimulation by 40 Gy-irradiated C3H sple- 
nocytes every three weeks. 
2.2. Generation of anti-JAK3 polyclonal antisera 
By RT-PCR and eDNA cloning, we obtained a partial eDNA clone 
which was first identified as a novel member of JAK kinase family and 
later revealed to be identical to JAK3 [15]. Based on the eDNA se- 
quence, a peptide corresponding to the hinge region between the two 
kinase domains of JAK3 (amino acid 924-938, SDPTPGIPSPRDELC) 
was synthesized and was coupled to keyhole limpet hemocyanin by 
glutaraldehyde and used for immunization of rabbits. 
2.3. Immunoprecipitation, SDS-PAGE and Western blotting 
Cells were harvested and starved in RPMI-1640 with 0.5% (w/v) of 
dialyzed bovine serum albumin (BSA) (Sigma) for 2-3 h before stimu- 
lation. Recombinant mouse IL-7 (UBI) was added and incubated for 
indicated time and lysed in ice-cold lysis buffer (50 mM Tris-HC1, pH 
7.5, 150 mM NaCI, 1% (v/v) Triton X-100, 100/zM sodium vanadate 
and 1 mM phenylmethylsulfonyl fluoride) at a concentration f 2 x 10 7 
cells/ml. Supernatant were separated from debris by centrifugation for 
10 rain at 4°C and were either directly used for SDS-PAGE as cell lysate 
or processed for immunoprecipitation as previously described y Har- 
low and Lane [16]. The cell lysates or immunoprecipitates were 
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subjected to 10% or 6% SDS-PAGE, respectively. Gels were transferred 
electrophoretically to nitrocellulose membrane (Schleicher and 
Schuell). The membranes were blocked in 5% (w/v) of BSA in Tris- 
buffered saline solution (TBS), incubated in rel vant primary antibody, 
and after washing were incubated in horseradish peroxidase-conjugated 
anti-mouse or anti-rabbit antibody (DAKOPATTS, Denmark). Pri- 
mary antibodies employed were anti-phosphotyrosine monoclonal anti- 
body (4GI0), polyclonal antisera against MAP kinase R1 (erkl-III), 
and MAP kinase R2 (erkl-CT), polyclonal rabbit antisera against 
JAK1 and JAK2. All these were purchased from UBI. Anti-TYK2 
antibody and anti-STAT1 antibody (polyclonal E-23 and monoclonal 
C-136) were purchased from Santa Cruz Biotechnology. Bands in the 
washed membrane were detected by th  enhanced hemiluminescence 
(ECL) system (Amersham LifeScience). The used membranes were 
stripped for re-probing by washing once in 2% SDS (w/v), 100 mM 
2-mercaptoethanol nd62.5 mM Tris-HC1, pH 6.8, at 50"C for 30 min 
and twice in PBS containing 0.1% (v/v) Tween-20 at room temperature 
for 10 rain. Competition study wasdone by pre-incubation of the 
anti-JAK3 antisera with the JAK3 specific peptide (100 gg/ml of anti- 
sera) for 1 h at4°C prior to addition of the mixture to cell lysate for 
immunoprecipitation. 
2.4. In vitro kinase assay 
The washed immunoprecipitates on protein A-Sepharose (Pharma- 
cia) were further washed once with kinase buffer (50mM NaC1, 5 mM 
MgCI2, 5 mM MnCI:, and 10 mM HEPES, pH 7.0) and incubated for 
5 min at room temperature in equal volume of kinase buffer containing 
0.25 mCi/ml [7)2p]ATP (Amersham Life Science). The reaction was 
stopped by adding equal volume of 2 x Laemmli's sample buffer (100 
mM Tris-HCl, pH 7.5, 20% (v/v) glycerol, 2 mM dithiothreitol, 2% 
(w/v) SDS and 0.004% (w/v) bromophenol blue) and boiling for 3 min. 
The proteins were separated by 6% SDS-PAGE and transferred onto 
nitrocellulose membrane and detected by exposing to X-ray film. The 
filter was then probed by anti-JAK3 antisera. 
3. Results and discussion 
3.1. Tyrosine phosphorylation ofJAK family kinases induced by 
IL-7 
Studies carried out in a series of mutants which were selected 
for their inability o respond to interferon (IFN)-~/fl or IFN-? 
or both evidently demonstrated that JAK1 and TYK2 were 
essential for an IFN-~/fl response and JAK1 and JAK2 were 
essential for an IFN-? response [9]. In addition, the homo- 
dimerization of IL-6 signal transducer gpl30 was shown to 
activate JAK2, JAK1 and to a lesser extent, TYK2 [9]. Re- 
cently, both JAK3 and JAK1 were shown to be involved in IL-2 
signalling [11]. These data suggested the requirement for two 
or more kinases in cooperation i the cytokine signalling proc- 
ess, though in the cases of IL-3 and IL-5, only JAK2 was 
supposed to be involved. Thereby we chose to examine the 
phosphorylation pattern of all the four identified JAK kinases 
upon stimulation by IL-7. As shown in Fig. 1, only the tyrosine 
phosphorylation of JAK3 was up-regulated by IL-7 stimula- 
tion, although both JAK1 and JAK3 had a high expression 
level at both protein and mRNA levels (as detected by North- 
ern blot analysis, data not shown). Probably in the case of IL-7, 
only one kinase is required presumably for signalling, at least 
in the cell line checked, or alternatively the phosphorylation of 
other JAKs was too weak to be detected in our system. On the 
other hand, we can not exclude the possible xistence of novel 
members of JAK family involving in the process. Interestingly, 
in previous tudies using human mature T cells [7,17], a protein 
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Fig. 1. Tyrosine phosphorylation of JAK family kinases in a helper T cell line (YT-5) by IL-7 stimulation. Cells (routinely, 2 x 107/lane was used) 
of YT-5 T cell clone were not stimulated (-) or stimulated (+) by IL-7 (20 ng/ml) for 5 rain. The cells were lys d and immunoprecipitated (IP) by 
the indicated antibodies or normal rabbit serum (NRS) or JAK3 peptide-treated anti-JAK3 antisera (100/~g of peptide/ml ofantisera) as described 
in section 2. The immuneprecipitates were separated by 6% of SDS-PAGE and transferred to nitrocellulose membrane. The filter was firs  probed 
with anti-phosphotyrosine monoclonal antibody 4G10 (anti-PTyr) and detected by ECL system. The used filter was then stripped and re-probed with 
the corresponding antibodies (bottom line) which were used for immunoprecipitation. Comparable amount of proteins were present in lanes of JAK1 
and JAK3. However, tyrosine phosphorylation w s bserved only in the lane of anti-JAK3 with IL-7 stimulation. 
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Fig. 2. Tyrosine phosphorylation a d in vitro activation of JAK3 in a helper T cell line (Y'I:5) by IL-7 stimulation. (A) Dose-dependent tyrosine 
phosphorylation f JAK3. The cells were unstimulated (-) or stimulated by 2, 20, or 200 ng/ml of IL-7 for 5 rain before cell lysis and then 
immtmoprecipitated by anti-JAK3 antisera. The precipitated materials were electrophoresed in 6% SDS-PAGE, transferred tonitrocellulose mem- 
branes and analyzed by immuno-blotting with anti-phosphotyrosine a tibody 4G10 (anti-PTyr). The same membrane was re-probed with anti-JAK3 
antisera. The detection was done using ECL system. JAK protein was present in all lanes (bottom lines), but tyrosine phosphorylation was detected 
after the stimulation and peak response was seen at dose of 20 ng/ml. (13) Time course of tyrosine phosphorylation f JAK3. The cells were not 
stimulated (0) or stimulated with 20 ng/ml of IL-7 for the indicated time and analyzed as described in Fig. 2A. Peak response was seen at 5 min after 
the stimulation. Bottom line shows a comparison of JAK3 protein level. (C) In vitro autophosphorylation of JAK3. Unstimulated (0) or stimulated 
cells by 20 ng/ml of IL-7 for the indicated time were immunoprecipitated by anti-JAK3 antisera. The 6% SDS-PAGE-separated proteins were 
transferred onto nitrocellulose membrane which was then exposed to a X-ray film. The same membrane was again probed with anti-JAK3 antisera. 
The peak of in vitro autophosphorylation was seen at 5 min after the stimulation. The bottom line indicate JAK3 protein level. 
of about 130 kDa was rapidly tyrosine phosphorylated when 
the cells were treated with IL-7. It is highly possible for that 
protein to be the human homolog of the murine JAK3 detected 
in our experiment. In order to confirm that the IL-7-regulated 
protein is JAK3, a competition experiment was done by using 
the JAK3 specific peptide which the anti-JAK3 antisera was 
raised against. The result showed a complete blockage by the 
peptide (Fig. 1). 
3.2. Dose- and time-dependent tyrosine phosphorylation and in 
vitro activation of kinase activity of JAK3 by 1L-7 
Fig. 2A shows a dose-dependent tyrosine phosphorylation 
pattern of JAK3 induced by IL-7. Coincident with previous 
findings showing that at 1 ng/ml [7], IL-7 stimulated the tyro- 
sine phosphorylation of four proteins including the 130 kDa 
one, we found that 2 ng/ml of IL-7 clearly up-regulated the 
magnitude of tyrosine phosphorylation of JAK3 and the in- 
creased osage (20 ng/ml) enhanced the extent of phosphoryla- 
tion greatly, but when further increased to 200 ng/ml, no obvi- 
ous enhancing effect was observed. The protein of JAK3 
detected with anti-JAK3 antisera by immuno-blotting was 
shown at the bottom of Fig. 2A,B,C. Thus we considered the 
concentration of 20 ng/ml as optimal and was used in all other 
experiments in this study. 
To see the time course of tyrosine phosphorylation f JAK3, 
we stimulated the cells with IL-7 for various time before prepar- 
ing cell lysate. Fig. 2B indicates that JAK3 was clearly 
phosphorylated 2 rain after stimulation, peaked at 5 min and 
then diminished. To link the tyrosine phosphorylation with 
enzymatic activity, in vitro autophosphorylation was per- 
formed. The results in Fig. 2C show a similar time course of 
the kinase activity as een in tyrosine phosphorylation (Fig. 
2B); i.e. the peak was again observed at 5 min after stimulation. 
The kinase activity was not precipitated in the presence of 
competing JAK3 peptide (data not shown). These results 
strongly indicated that JAK3 was regulated by IL-7 for its 
tyrosine phosphorylation a d kinase activity in vitro as well. 
3.3. Tyrosine phosphorylation of STAT1 and MAP kinase by 
IL-7 
STATs is a family of transcription factors composed of at 
least four members, and recent studies suggested its response 
to JAKs-mediated IFNs and IL-6 stimuli and its role in linking 
JAK kinases with cytokine-responsive gene expression [18,19]. 
In this study, when checking the phosphorylation pattern of 
whole cell lysate, we found that a protein with the same size as 
STATla (p91) was up-regulated for its tyrosine phosphoryla- 
tion by IL-7 (Fig. 3, middle arrow). By re-probing with anti- 
STAT1 antisera which recognize both STATla and fl (p91 and 
p84), the antibody identified a band at 90 kDa which comi- 
grated with the above mentioned tyrosine phosphorylated pro- 
tein (Fig. 3, right and upper panel). Another protein showing 
elevated tyrosine phosphorylation by IL-7 stimulation (Fig. 3, 
lower arrow) had a size of about 44 kDa and was revealed 
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Fig. 3. Tyrosine phosphorylation pattern of the whole cell lysate of a helper T cell line (YT-5) stimulated by IL-7. The cells were not stimulated (0) 
or stimulated with 20ng/ml of IL-7 by the indicated time andthe cell lysate was subjected to 10% SDS-PAGE and transferred to nitrocellulose 
membrane. The membrane w s first probed with anti-phosphotyrosine antibody 4G10 (anti-PTyr: the left figure) and th n re-p obed with anti-p91/84 
(STATI~: the right upper), anti-MAPK R1 (erk I-III: the right lower) and anti-JAK3 antibodies (data not shown), respectively. The upper arrow 
indicates the band etected by anti-JAK3, the middle arrow indicates the band tected by anti-p91/84 and the lower arrow indicates the band etected 
by anti-MAPK R1. Both STATI~ and p44 of MAPK were significantly tyrosine phosphorylated after IL-7 stimulation and the response peaked 
between 5 and 15 min. 
presumably to be the p44 isoform of MAP kinases by re-prob- 
ing with anti-MAP kinase R1 (anti-erkl-III) (Fig. 3, right and 
lower panel). These two proteins also showed a similar time- 
dependent kinetics of phosphorylation as observed in JAK3 
(Fig. 3, upper arrow) which was detected by re-probing with 
anti-JAK3 (data not shown). To further prove these findings, 
we carried out immunoprecipitation experiments u ing two ad- 
ditional antibodies against MAP kinases (anti-erkl-CT) and 
STAT1 (monoclonal ntibody C-136) which can be applied for 
immunoprecipitation. As expected and shown in Fig. 4A, the 
p44 isoform of MAP kinases howed a significant change in 
tyrosine phosphorylation when the cells were treated with IL-7; 
i.e. tyrosine phosphorylation first decreased 2 min after stimu- 
lation, increased thereafter and peaked 15 min after the treat- 
ment. STAT10c (the p91 isoform) also displayed a significant 
increase in tyrosine phosphorylation 15 min after the cells were 
A 
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Fig. 4. Tyrosine phosphorylation of p44 of MAP kinases and STATI~z (p91) induced by IL-7 stimulation. The c lls were not stimulated (0) or 
stimulated with 20 ng/ml of IL-7 for the indicated time. Cell lysates were prepared and immunoprecipitated (IP) either with: (A) polyclonal antiserum 
against MAP kinases (erkl-CT), or (B) monoclonal antibody against STAT1 (ISGF-3 p84/91). The immunoprecipitates were separated by 10% (A) 
or 6% (B) SDS-PAGE and transferred to nitrocellulose membrane. The membranes were probed with anti-phosphotyrosine monoclonal antibody 
(4G10, anti-PTyr) and detected by ECL system. The arrows indicate the bandswith appropriate size of p44 of MAP kinase (A) and p91 of STATI 
(B), respectively. Both f these proteins showed a significant level of yrosine phosphorylation after IL-7 stimulation. 
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stimulated with IL-7 (Fig. 4B). Therefore, these data strongly 
support hat two different signal pathways may be involved in 
IL-7 signalling. 
In this respect, one report [7] demonstrated that two proteins 
of about 95 kDa and 45 kDa showed a significant level of 
tyrosine phosphorylation i  human T cells after stimulation 
with IL-7, although they were not characterized by immuno- 
chemical method. In previous tudies, a direct association be- 
tween JAK1 and STAT10t (p91) was suggested in the IFNs and 
IL-6 signalling pathways [18,19], therefore a similar association 
between JAK3 and STAT1o, might also exist in IL-7 singalling. 
Moreover, MAP kinases were tyrosine phosphorylated and 
activated by a number of cytokines, including IL-6, IL-11, 
leukemia inhibitory factor (LIF), oncostatin M [20] and IL-12 
[21], and tyrosine kinases were suggested to be required for the 
activation of MAP kinases [20]. On the other hand, phospholip- 
ase C-y1, a key molecule in the phospholipid signal pathway 
after T cell antigen receptor (TCR) engagement, was not acti- 
vated by IL-7 [16]. Taken together, these results may suggest 
that both the STATI~z and p44 of MAP kinases might be 
phosphorylated and activated by IL-7 induction and this IL-7- 
induced response may use different signalling pathways from 
the TCR. 
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